Clinicians Seek Amoxicillin Warning for Semen Exposure — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- The woman, who had a history of penicillin allergy, developed anaphylaxis five minutes after ejaculation; her partner had taken amoxicillin for a sinus infection six hours before unprotected vaginal sex, although his doctor had explicitly reassured him that she faced no risk.
- Cassim Akhoon and his colleagues confirmed her penicillin allergy about a year later with a skin test and concluded that amoxicillin exposure through semen was the most likely cause.
- Medicines and Healthcare Products Regulatory Agency will decide whether to update amoxicillin leaflets after receiving the clinical team’s findings; the team considers the evidence strong enough to list the rare semen-exposure risk and wants it included in medical training.
- Akhoon said antibiotics enter the bloodstream and reach the prostate and seminal vesicles; prior studies found amoxicillin in urine and suggested it can persist in the urethra until ejaculation flushes it out.
- Earlier case reports described a woman developing anaphylaxis after amoxicillin exposure during oral sex; the team said there is no evidence that antibiotic transfer through vaginal fluid causes allergic reactions in sexual partners.
- The clinical team noted that around 1 per cent of people have penicillin allergies confirmed by skin-prick tests, while anaphylaxis from this form of drug exposure is extremely rare.
- Patrick Yong said informed patients can use condoms or avoid sex until an antibiotic course ends; consultant allergist Chris Rutkowski said the exposure should be taught in medical training because the cost of missing it is high.
Why it matters: For the roughly 1% of people with penicillin allergies, the proposed leaflet warnings and clinician training address a suspected route to anaphylaxis and support condom use or avoiding sex during treatment. The Medicines and Healthcare Products Regulatory Agency’s decision on amoxicillin is the concrete next step; evidence does not yet support warnings for other drugs or vaginal-fluid transmission.
Ask SkimNews
